NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Apoptosis



Adenosine and deoxyadenosine induced apoptosis in human breast cancer



December 8th, 2005

Adenosine (Ado) and deoxyadenosine (dAdo) were used to induce apoptosis in estrogen receptor-positive and -negative human breast cancer cells.

"In this study we have examined the cytotoxic effects of different concentrations of Ado and dAdo on human breast cancer cell lines. Ado and dAdo alone had little effect on cell cytotoxicity," scientists writing in the journal Cell Proliferation reported.

"However, in the presence of adenosine deaminase (ADA) inhibitor, EHNA, adenosine and deoxyadenosine led to significant growth inhibition of cells of the lines tested. Ado/EHNA and dAdo/EHNA-induced cell death was significantly inhibited by NBTI, an...


Source: Women's Health Weekly (2005-12-08)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login